Indapamide

CHEMBL406 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
365.8 g/mol
LogP
2.9
Phase
4

This thiazide-like diuretic is used to treat high blood pressure and fluid retention (edema) associated with heart failure. It reduces blood pressure by promoting sodium and water excretion in the kidneys, decreasing blood volume, and also by directly relaxing blood vessels. It is often preferred for hypertension due to its neutral effect on blood lipids and glucose.

Berat Molekul

365,8000 g/mol

LogP

2,90

TPSA

101,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Mekanisme Kerja

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1

InChI

InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

Molecular Formula

C16H16ClN3O3S

HBD / HBA

2 / 5

Ikatan yang Dapat Dirotasi

3

Atom Berat

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This thiazide-like diuretic is used to treat high blood pressure and fluid retention (edema) associated with heart failure. It reduces blood pressure by promoting sodium and water excretion in the kidneys, decreasing blood volume, and also by directly relaxing blood vessels. It is often preferred for hypertension due to its neutral effect on blood lipids and glucose.

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Yes, Indapamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL406. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3702. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.